Kojic acid is a melanin-inhibiting active derived from fungal fermentation (most commonly Aspergillus oryzae). Its safety profile for the periorbital area is acceptable at low concentrations when formulated correctly, but it requires careful handling compared to other brightening actives.
In terms of skin tolerance, kojic acid can cause contact dermatitis in sensitive individuals, particularly at concentrations above 1%. The eye area has thinner, more permeable skin than the rest of the face, which means actives penetrate more readily and irritation potential is higher. A well-formulated eye cream will buffer kojic acid within a pH range of 4.5 to 5.5 and include a soothing co-system — niacinamide, allantoin, or panthenol are common — to offset potential reactivity. Ophthalmological testing (non-irritating to eyes, tested per ISO 10093 or similar) is worth requesting from manufacturers, especially if you plan retail distribution where returns and complaints matter.
On the regulatory side, the picture varies by market. In the United States, kojic acid in a cosmetic product has no specific concentration limit set by the FDA; the manufacturer is responsible for safety substantiation. In the European Union, kojic acid is listed in Annex III of EC Regulation 1223/2009 as a restricted substance, currently permitted at a maximum of 1% in face creams and hand creams — eye creams occupy a gray zone that should be clarified with a regulatory consultant. The UK follows similar restrictions post-Brexit under the UK Cosmetics Regulation. Japan classifies kojic acid as a quasi-drug whitening agent under a separate regulatory pathway; if you plan to sell in Japan, a different registration and labeling structure is required. Canada's Cosmetic Ingredient Hotlist should also be reviewed.
Alpha-arbutin is generally better tolerated than kojic acid and faces fewer regulatory restrictions globally, making it the preferred primary brightening active in many eye cream formulas, with kojic acid included as a secondary active at lower concentrations.
The most common first-timer mistake is formulating at the maximum permitted kojic acid concentration in a single market without checking whether those levels are also permitted in all target export markets, leading to costly reformulation before expansion.
AJ Cosmo Labs connects you with cosmetic chemists and regulatory consultants who specialize in brightening actives across multiple markets, so you can validate your formula's regulatory compliance before committing to a production run.
Ingredients in this answer: Kojic Acid · Niacinamide · Allantoin · Panthenol · Alpha-Arbutin
Read the full guide on Private Label Arbutin Kojic Acid Eye Cream – Low MOQ →